Gene · 7185
Papers2,530
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,530
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Novel Functions of Integrins as Receptors of CD154: Their Role in Inflammation and Apoptosis. | Cells | 2022 | 35681441 | PubTator, text mining | PubMed |
| A single-cell map of dynamic chromatin landscapes of immune cells in renal cell carcinoma. | Nat Cancer | 2022 | 35668194 | PubTator, text mining | PubMed |
| PD-L1 Mediates IFNγ-Regulation of Glucose but Not of Tryptophan Metabolism in Clear Cell Renal Cell Carcinoma. | Front Oncol | 2022 | 35656514 | PubTator, text mining | PubMed |
| Crosstalk between Body Microbiota and the Regulation of Immunity. | J Immunol Res | 2022 | 35647199 | PubTator, text mining | PubMed |
| Molecular Signature of Neuroinflammation Induced in Cytokine-Stimulated Human Cortical Spheroids. | Biomedicines | 2022 | 35625761 | PubTator, text mining | PubMed |
| Influence of a Polyherbal Choline Source in Dogs: Body Weight Changes, Blood Metabolites, and Gene Expression. | Animals (Basel) | 2022 | 35625159 | PubTator, text mining | PubMed |
| Targeting TROY-mediated P85a/AKT/TBX3 signaling attenuates tumor stemness and elevates treatment response in hepatocellular carcinoma. | J Exp Clin Cancer Res | 2022 | 35610614 | PubTator, text mining | PubMed |
| Salt-inducible kinase 3 protects tumor cells from cytotoxic T-cell attack by promoting TNF-induced NF-κB activation. | J Immunother Cancer | 2022 | 35606086 | PubTator, text mining | PubMed |
| Association Study of Anticitrullinated Peptide Antibody Status with Clinical Manifestations and SNPs in Patients Affected with Rheumatoid Arthritis: A Pilot Study. | Dis Markers | 2022 | 35601739 | PubTator, text mining | PubMed |
| Comparison of DNA Methylation Changes Between the Gestation Period and the After-Delivery State: A Pilot Study of 10 Women. | Front Nutr | 2022 | 35600817 | PubTator, text mining | PubMed |
| A Novel TNFSF-Based Signature Predicts the Prognosis and Immunosuppressive Status of Lower-Grade Glioma. | Biomed Res Int | 2022 | 35592520 | PubTator, text mining | PubMed |
| SGK1 negatively regulates inflammatory immune responses and protects against alveolar bone loss through modulation of TRAF3 activity. | J Biol Chem | 2022 | 35588785 | PubTator, text mining | PubMed |
| Feasibility and clinical utility of comprehensive genomic profiling of hematological malignancies. | Cancer Sci | 2022 | 35579198 | PubTator, text mining | PubMed |
| Th1 cytokines synergize to change gene expression and promote corticosteroid insensitivity in pediatric airway smooth muscle. | Respir Res | 2022 | 35578269 | PubTator, text mining | PubMed |
| Dendritic Cells and Their Immunotherapeutic Potential for Treating Type 1 Diabetes. | Int J Mol Sci | 2022 | 35563276 | PubTator, text mining | PubMed |
| Implication of genetic variants in primary microRNA processing sites in the risk of multiple sclerosis. | EBioMedicine | 2022 | 35561450 | PubTator, text mining | PubMed |
| Single-cell sequencing reveals the heterogeneity and intratumoral crosstalk in human endometrial cancer. | Cell Prolif | 2022 | 35560676 | PubTator, text mining | PubMed |
| TRAP1 regulates the response of colorectal cancer cells to hypoxia and inhibits ribosome biogenesis under conditions of oxygen deprivation. | Int J Oncol | 2022 | 35543151 | PubTator, text mining | PubMed |
| N6-methyladenosine-modified TRAF1 promotes sunitinib resistance by regulating apoptosis and angiogenesis in a METTL14-dependent manner in renal cell carcinoma. | Mol Cancer | 2022 | 35538475 | PubTator, text mining | PubMed |
| Trovafloxacin drives inflammation-associated drug-induced adverse hepatic reaction by changing macrophage polarization. | Toxicol In Vitro | 2022 | 35537566 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7185/papers?page=20